We found that the mRNA levels of PTGDS and its receptor prostaglandin D2 receptor (PTGDR) were downregulated in tumours with larger size, higher stage, and higher histological grade, suggesting that PTGDS could serve as a protective factor (Figure 9). Here, PTGDR is linked to neoplasm.